Polypeptide and method of producing IMP using the same

US11180754B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11180754-B2
Application numberUS-201916425897-A
CountryUS
Kind codeB2
Filing dateMay 29, 2019
Priority dateDec 15, 2017
Publication dateNov 23, 2021
Grant dateNov 23, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to a novel polypeptide having an activity of exporting 5′-inosine monophosphate, a microorganism comprising the same, a method for preparing 5′-inosine monophosphate using the same, and a method for increasing export of 5′-inosine monophosphate.

First claim

Opening claim text (preview).

The invention claimed is: 1. A polynucleotide encoding a protein variant, wherein the protein variant is capable of exporting 5′-inosine monophosphate and comprises an amino acid sequence that is identical to SEQ ID NO:2 except that (i) the 2nd amino acid, (ii) the 64th amino acid, or (iii) the 2nd amino acid and the 64th amino acid in the amino acid sequence of SEQ ID NO:2 are each substituted with another amino acid. 2. A vector comprising the polynucleotide of claim 1 .

Assignees

Inventors

Classifications

  • C12N15/11Primary

    DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity} · CPC title

  • C07K14/705Primary

    Receptors; Cell surface antigens; Cell surface determinants {(tumour specific antigens C07K14/4748)} · CPC title

  • for Corynebacterium; for Brevibacterium · CPC title

  • C12P19/32Primary

    having a condensed ring system containing a six-membered ring having two N-atoms in the same ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide · CPC title

  • Bacterial isolates · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11180754B2 cover?
The present disclosure relates to a novel polypeptide having an activity of exporting 5′-inosine monophosphate, a microorganism comprising the same, a method for preparing 5′-inosine monophosphate using the same, and a method for increasing export of 5′-inosine monophosphate.
Who is the assignee on this patent?
Cj Cheiljedang Corp
What technology area does this patent fall under?
Primary CPC classification C12N15/11. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 5 related publications on this page (citations in our corpus or others sharing the same primary CPC).